Timber Pharmaceuticals announces NYSE acceptance of plan to regain listing compliance

seekingalpha2023-09-19

Timber Pharmaceuticals (NYSE:TMBR) on Monday announced that the NYSE American LLC has accepted the company’s business plan to regain compliance with the continued listing rules. On September 12, the ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2368948173?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2023-09-19 04:11","share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","id":"2368948173","market":"us","top_or_hot":-1,"title":"Timber Pharmaceuticals announces NYSE acceptance of plan to regain listing compliance","media":"seekingalpha","content":"<div>\n<p>Timber Pharmaceuticals (NYSE:TMBR) on Monday announced that the NYSE American LLC has accepted the company’s business plan to regain compliance with the continued listing rules. On September 12, the ...</p>\n\n<a href=\"https://seekingalpha.com/news/4012913-timber-pharmaceuticals-announces-nyse-acceptance-of-plan-to-regain-listing-compliance\">Source Link</a>\n\n</div>\n","source":"seekingalpha","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Timber Pharmaceuticals announces NYSE acceptance of plan to regain listing compliance</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTimber Pharmaceuticals announces NYSE acceptance of plan to regain listing compliance\n</h2>\n\n<h4 class=\"meta\">\n\n\n2023-09-19 04:11 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/4012913-timber-pharmaceuticals-announces-nyse-acceptance-of-plan-to-regain-listing-compliance><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Timber Pharmaceuticals (NYSE:TMBR) on Monday announced that the NYSE American LLC has accepted the company’s business plan to regain compliance with the continued listing rules. On September 12, the ...</p>\n\n<a href=\"https://seekingalpha.com/news/4012913-timber-pharmaceuticals-announces-nyse-acceptance-of-plan-to-regain-listing-compliance\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4007","symbol_name":"制药","start_time":0,"source_url":"https://seekingalpha.com/news/4012913-timber-pharmaceuticals-announces-nyse-acceptance-of-plan-to-regain-listing-compliance","article_id":"2368948173","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2368948173","pubTimestamp":1695067916,"columns":[],"sourceInfo":{"source_id":"seekingalpha","name":"Seeking Alpha"},"weMediaInfo":null,"summary":"Timber Pharmaceuticals  on Monday announced that the NYSE American LLC has accepted the company’s business plan to regain compliance with the continued listing rules. On September 12, the NYSE American provided a notice to the company accepting its plan to regain compliance and has granted to the company a plan period through December 28, 2024.  During the plan period, the company will be subject to periodic review to determine whether it is making progress consistent with the accepted plan. Source: Press Release    More on Timber Pharmaceuticals  Seeking Alpha’s Quant Rating on Timber Pharmaceuticals Historical earnings data for Timber Pharmaceuticals Financial information for Timber Pharmaceuticals Timber to be taken private by LEO Pharma, stock soars 100% Timber Pharmaceuticals receives NYSE notice on non-compliance","collect":0,"end_time":0,"defaultTopTitle":"seekingalpha.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4007":"制药","NYSE":"纽交所"},"translate_title":"Timber Pharmaceuticals宣布纽约证券交易所接受重新获得上市合规性的计划","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"NYSE":1,"TMBR":1},"content_text":"Timber Pharmaceuticals (NYSE:TMBR) on Monday announced that the NYSE American LLC has accepted the company’s business plan to regain compliance with the continued listing rules. On September 12, the NYSE American provided a notice to the company accepting its plan to regain compliance and has granted to the company a plan period through December 28, 2024.  During the plan period, the company will be subject to periodic review to determine whether it is making progress consistent with the accepted plan. Source: Press Release    More on Timber Pharmaceuticals  Seeking Alpha’s Quant Rating on Timber Pharmaceuticals Historical earnings data for Timber Pharmaceuticals Financial information for Timber Pharmaceuticals Timber to be taken private by LEO Pharma, stock soars 100% Timber Pharmaceuticals receives NYSE notice on non-compliance","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2368948173"}